Market Overview

UPDATE: Soaring 19%, Deutsche Bank Initiates Coverage on Arrowhead Research

Related ARWR
Mid-Afternoon Market Update: Crude Oil Drops 5%; Alpha and Omega Semi Shares Gain On Earnings Beat
20 Biggest Mid-Day Gainers For Thursday

Rating reports today from Deutsche Bank includes analyst Alethia Young initiating coverage on Arrowhead Research (NASDAQ: ARWR). The initial rating is a Buy with a price target of $45.

Young notes, "Arrowhead is an early stage platform company that we believe could have the market cap potential of $4-5B as it becomes de-risked. The company's lead target is ARC-520 for Hepatitis B (HBV). Our HBV deep dive suggests ARC-520 could grow the market from $2B to $5B and see $5.2B peak sales WW."

Some risks that were mentioned includes possible safety and efficacy issues relating to drug and platform technology. Possible clinical delays on ARC-520 may also hinder then ability of ARWR to reach its potential.

ARWR closed previous trading session at $21.14 and is currently trading around the $25.23 mark, up over 19%. The price target of $45 displays a 170% upside from current trading prices.

Latest Ratings for ARWR

Nov 2016JefferiesMaintainsHold
Nov 2016William BlairDowngradesOutperformMarket Perform
Nov 2016PiperJaffrayDowngradesOverweightNeutral

View More Analyst Ratings for ARWR
View the Latest Analyst Ratings

Posted-In: Deutsche BankNews Price Target Initiation Markets Analyst Ratings


Related Articles (ARWR)

View Comments and Join the Discussion!